Stimcell Energetics (STME) Consolidated Net Income (2016 - 2024)
Stimcell Energetics' quarterly Consolidated Net Income came in at -$124957.0 in Q2 2024, down 57.41% year-on-year from -$293397.1 in Q2 2023, and down 85.0% quarter-over-quarter from -$67546.0 in Q1 2024.
Stimcell Energetics has reported Consolidated Net Income for 9 years, with the latest figure at -$124957.0 in Q2 2024.
- For the quarter ending Q2 2024, Consolidated Net Income fell 57.41% year-over-year to -$124957.0; the trailing twelve-month figure through Feb 2025 stood at -$124957.0 (up 56.07% YoY), and the FY2024 full-year result was -$330003.0, up 33.34% from the prior year.
- Consolidated Net Income for Q2 2024 stood at -$124957.0, down from -$67546.0 in the prior quarter.
- The five-year high for Consolidated Net Income was -$60547.0 in Q4 2023, with the low at -$258815.0 in Q1 2020.
- Average Consolidated Net Income over 5 years is -$155013.6, with a median of -$158623.0 recorded in 2022.
- Peak annual rise in Consolidated Net Income reached 79.07% in 2020, while the deepest fall reached 259.64% in 2020.
- Tracing STME's Consolidated Net Income over 5 years: stood at -$189336.0 in 2020, then increased by 7.06% to -$175977.0 in 2021, then rose by 18.85% to -$142813.0 in 2022, then soared by 57.6% to -$60547.0 in 2023, then plunged by 106.38% to -$124957.0 in 2024.
- The last three Consolidated Net Income figures came in at -$124957.0 (Q2 2024), -$67546.0 (Q1 2024), and -$60547.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Stimcell Energetics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -124,957.00 |
| Feb 29, 2024 | -67,546.00 |
| Nov 30, 2023 | -60,547.00 |
| Aug 31, 2023 | -76,953.00 |
| May 31, 2023 | -79,383.00 |
| Feb 28, 2023 | -118,161.00 |
| Nov 30, 2022 | -142,813.00 |
| Aug 31, 2022 | -154,685.00 |
| May 31, 2022 | -162,561.00 |
| Feb 28, 2022 | -119,489.00 |
| Nov 30, 2021 | -175,977.00 |
| Aug 31, 2021 | -239,352.00 |
| May 31, 2021 | -187,629.00 |
| Feb 28, 2021 | -179,008.00 |
| Nov 30, 2020 | -189,336.00 |
| Aug 31, 2020 | -201,202.00 |
| May 31, 2020 | -251,830.00 |
| Feb 29, 2020 | -258,815.00 |
| Nov 30, 2019 | -303,488.00 |
| Aug 31, 2019 | -245,287.00 |
| May 31, 2019 | -1.20 Mn |
| Feb 28, 2019 | 162,120.00 |
| Nov 30, 2018 | 122,221.00 |
| Aug 31, 2018 | 238,794.00 |
| May 31, 2017 | 348,616.00 |
| Feb 28, 2017 | -295,671.00 |
| Nov 30, 2016 | -247,275.00 |
| Aug 31, 2016 | -272,562.00 |
| May 31, 2016 | -329,052.00 |
| Feb 29, 2016 | -296,015.00 |